Allied Market Research

Global Glycobiology Market - Opportunity and Forecast, 2017-2023

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the investment pockets.

 

Portland, OR -- (SBWIRE) -- 07/27/2017 -- Glycobiology is the study of entire biology that includes structure and function of molecules containing carbohydrates (sugar and saccharides) also called as glycans. It is very helpful in biotechnological research and biomedicine. Carbohydrates control almost all the aspects of cellular processing that involves cell-cell interactions, adhesion mechanisms, signalling for growth factors, blood clotting, regulating hormonal activity, and it also directs embryonic development.

Glycobiology market is in the emerging state mainly due to the increase in expenditure by different pharmaceutical companies on R&D. In addition, increase in activities such as drug discovery, government expenditure, technological advancement, public and private investments, and grants and funds for the development of more advanced technologies in the field of R&D. However, factors such as high cost associated with the imaging process, stringent government policies, and lack of skilled technicians impede the market growth.

Get full summary of the Report:https://www.alliedmarketresearch.com/glycobiology-market

The global glycobiology market is segmented based on product, application, end-user, and geography. Based on product, the market is classified into reagents, instruments, kits, and enzymes. Reagents are further sub-segmented into Monosaccharides, Glycoproteins, Oligosaccharides, and others. Instruments are further sub-divided into HPLC, antibody arrays, lectin arrays, MALDI-TOF, mass spectroscopy, and others. Kits are further sub-segmented into glycan release kits, glycan labeling kits, glycan purification kits, and others. Enzymes are further sub-classified into neuraminidases, glycosyltransferases, glycosidases, and others. Based on application, it is categorized into drug discovery and development, immunology, diagnostics, oncology, and others. Based on end-user, the market is classified into Pharmaceutical and Biotechnology Companies and research laboratories. The market is analyzed on the basis of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

Get sample of the Report:https://www.alliedmarketresearch.com/request-toc-and-sample/2194

By Product

-Reagents
-Monosaccharides
-Glycoproteins
-Oligosaccharides
-Others

Instruments
-HPLC
-Antibody arrays
-Lectin arrays
-MALDI-TOF
-Mass spectroscopy

Others
-Kits
-Glycan Release Kits
-Glycan Labeling Kits
-Glycan Purification Kits
-Others
-Enzymes
-Neuraminidases
-Glycosyltransferases
-Glycosidases
-Others
By Application

-Drug Discovery and Development
-Immunology
-Diagnostics
-Oncology
-Others

By End-User

-Pharmaceutical and Biotechnology Companies
-Research Laboratories

By Geography

North America
-U.S.
-Canada
-Mexico

Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe

Asia-Pacific
-Japan
-China
-India
-Rest of Asia-Pacific

LAMEA
-Latin America
-Middle East
-Africa